Sign In
Buy ADAP
$0.0549
+0 (+0%)
At Close: Feb 20, 2026
- Preclinical data validate that human T-cells expressing a TCR targeting mesothelin, independent of HLA recognition, can kill human tumor cells -
Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2021 Results - Earnings Call Transcript
09:29am, Friday, 07'th May 2021
Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2021 Results - Earnings Call Transcript
Adaptimmune Therapeutics PLC (ADAP) CEO Adrian Rawcliffe on Q4 2020 Results - Earnings Call Transcript
02:07pm, Thursday, 25'th Feb 2021
Adaptimmune Therapeutics PLC (ADAP) CEO Adrian Rawcliffe on Q4 2020 Results - Earnings Call Transcript
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
07:30am, Thursday, 25'th Feb 2021
- Outlined strategy to build integrated cell therapy company and the Company's “2-2-5-2” five-year core value drivers -
Adaptimmune: Clear Leader In TCR Therapies Targeting Solid Tumors, Speculative Investment
08:00am, Thursday, 10'th Dec 2020
Immense potential, TCR therapy leader, but early stage. Science looks excellent with some proof of concept but risks, especially toxicity risks, abound.
- SPEARHEAD-1 enrolment on track; planning to launch ADP-A2M4 in 2022 in the US for people with synovial sarcoma -
- Data support confidence in SPEARHEAD-1 as a registrational trial -
- Data support continued development of ADP-A2M4CD8 -
2 Cancer Stocks That Could Make You Filthy Rich
10:00am, Sunday, 08'th Nov 2020
Adaptimmune Therapeutics and Trillium Therapeutics could be big winners for early shareholders.
Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q3 2020 Results - Earnings Call Transcript
10:18pm, Thursday, 05'th Nov 2020
Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q3 2020 Results - Earnings Call Transcript
Adaptimmune Reports Q3 Financial Results and Business Update
07:30am, Thursday, 05'th Nov 2020
- Data from Phase 1 Trial with ADP-A2AFP in liver cancer presented at ILC confirm safety profile and demonstrate potential benefit for patients -
Oct 09, 2020 (CDN Newswire via Comtex) --
To gain insightful analysis and to have comprehensive understanding of the Spear Phishing Market and its commercial...
360 S9 Robot Vacuum Cleaner review: A perfect fit for small homes
10:00am, Wednesday, 07'th Oct 2020
Keeping your floors clean is a real chore. But reliable robot vacuums like the 360 S9 can help out with that.
Adaptimmune Therapeutics (ADAP) Investor Presentation - Slideshow
10:53am, Friday, 11'th Sep 2020Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
08:12am, Saturday, 22'nd Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
